Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

26.64
Delayed Data
As of Apr 29
 -0.33 / -1.22%
Today’s Change
20.07
Today|||52-Week Range
42.48
-5.83%
Year-to-Date

Today’s Trading

Previous close26.97
Today’s open26.74
Day’s range26.21 - 27.08
Volume163,782
Average volume (3 months)331,568
Market cap$881.7M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+68.75%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio95.7
Price/Sales11.37
Price/Book7.15

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc-0.68-4.99%
TBPHTheravance Biopharma...-0.41-1.94%
MACKMerrimack Pharmaceut...-0.21-2.88%
SUPNSupernus Pharmaceuti...-0.01-0.06%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs